ID
31178
Descripción
Study ID: 104505 Clinical Study ID: BEX104505 Study Title: Phase II Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00950755 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin
Palabras clave
Versiones (1)
- 25/7/18 25/7/18 -
Titular de derechos de autor
see clinicaltrials.gov
Subido en
25 de julio de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Iodine 131 B1 Antibody for B-Cell Lymphomas NCT00950755
Patient Withdrawal from Study
- StudyEvent: ODM
Descripción
Withdrawal from study
Alias
- UMLS CUI-1
- C0422727 (Patient withdrawn from trial)
- SNOMED
- 185924006
Descripción
Withdrawal from study; reason
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0422727 (Patient withdrawn from trial)
- SNOMED
- 185924006
- UMLS CUI [1,2]
- C0085978 (Causations)
Descripción
Withdrawal from study, explanation
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0422727 (Patient withdrawn from trial)
- SNOMED
- 185924006
- UMLS CUI [1,2]
- C0681841 (Explanation)
- LOINC
- LA15331-4
Similar models
Patient Withdrawal from Study
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0085978 (UMLS CUI [1,2])
C0681841 (UMLS CUI [1,2])
Sin comentarios